PEP/NEWS — Peptide intel. Daily.

GLP-1 DRUGS NOW UNDER REVIEW AS POTENTIAL GEROTHERAPEUTICS — NOT JUST OBESITY TREATMENTSDNA METHYLATION CLOCKS VARY SIGNIFICANTLY BY TISSUE TYPE ACROSS 17 ORGANS — NATURE AGING META-ANALYSISFGF21 GENE THERAPY EXTENDED MALE MOUSE MEDIAN LIFESPAN BY 20% WHEN GIVEN LATE IN LIFESLEEP DEPRIVATION RAISES SV2A SYNAPTIC DENSITY MARKER IN HUMAN BRAIN — PLOS BIOLOGYSENESCENT CELLS DRIVE TUMOR BLOOD VESSEL GROWTH VIA SASP SIGNALING — AGING CELL REVIEWHIF-1α OVEREXPRESSION TRIGGERS CARTILAGE-DESTROYING ANGIOGENESIS IN JOINT TISSUEBIOLOGICAL AGE ACCELERATION LINKED TO RISING EARLY-ONSET SOLID CANCER RATES IN YOUNGER ADULTSEPIGENETIC AGE REDUCTION NOW DOCUMENTED FOR MULTIPLE LIFESTYLE AND PHARMACEUTICAL INTERVENTIONS IN HUMANS GLP-1 DRUGS NOW UNDER REVIEW AS POTENTIAL GEROTHERAPEUTICS — NOT JUST OBESITY TREATMENTSDNA METHYLATION CLOCKS VARY SIGNIFICANTLY BY TISSUE TYPE ACROSS 17 ORGANS — NATURE AGING META-ANALYSISFGF21 GENE THERAPY EXTENDED MALE MOUSE MEDIAN LIFESPAN BY 20% WHEN GIVEN LATE IN LIFESLEEP DEPRIVATION RAISES SV2A SYNAPTIC DENSITY MARKER IN HUMAN BRAIN — PLOS BIOLOGYSENESCENT CELLS DRIVE TUMOR BLOOD VESSEL GROWTH VIA SASP SIGNALING — AGING CELL REVIEWHIF-1α OVEREXPRESSION TRIGGERS CARTILAGE-DESTROYING ANGIOGENESIS IN JOINT TISSUEBIOLOGICAL AGE ACCELERATION LINKED TO RISING EARLY-ONSET SOLID CANCER RATES IN YOUNGER ADULTSEPIGENETIC AGE REDUCTION NOW DOCUMENTED FOR MULTIPLE LIFESTYLE AND PHARMACEUTICAL INTERVENTIONS IN HUMANS

Last updated June 29, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

Featured Briefs

▶ Video

WHAT TO STACK WITH IGF-1 LR3

Are you wondering what to stack with IGF-1 LR3 without increasing risks or making costly mistakes? I break down how IGF-1 LR3 works in the body, what it targets, and why timing, cycling, and lab testing matter when stacking peptides. I als

Regan Archibald

More Headlines